Abstract | BACKGROUND: METHODS: Twenty patients with moderate to severe AR were enrolled in this study and the expression of MUC5AC, IL-17A, and glucocorticoid receptor beta (GR beta) was detected using immunochemical staining and quantitative reverse transcription polymerase chain reaction (RT-PCR) before and after treatment with fluticasone propionate (FP) nasal spray for 4 weeks, respectively. In addition, the effects of FP on IL-13- and IL-17A-induced MUC5AC and GR beta were also evaluated in the primarily cultured human nasal epithelial cells (HNECs) in vitro. RESULTS: The increased MUC5AC expression was associated with IL-17A levels in AR, and IL-17A was found to affect the inhibition of MUC5AC by corticosteroid treatment. Both IL-13 and IL-17A significantly promoted MUC5AC mRNA expression in HNECs, and FP treatment was able to significantly inhibit MUC5AC mRNA expression in HNECs induced by IL-13 but not for that induced by IL-17A. Also, IL-17A but not IL-13 promoted GR beta mRNA expression in HNECs, which was not affected by administration of corticosteroid. CONCLUSION: Our results suggest that the sensitivity of MUC5AC to topical corticosteroid is negatively associated with IL-17A in AR patients. This might help us to gain more insight into the pathophysiology and the pharmacotherapeutic mechanisms on AR treatment.
|
Authors | Haocheng Tang, Hongtian Wang, Jing Bai, Minghong Ding, Wenlong Liu, Wentong Xia, Qing Luo, Geng Xu, Huabin Li, Jugao Fang, Nasal Health Group and China |
Journal | American journal of rhinology & allergy
(Am J Rhinol Allergy)
2012 Sep-Oct
Vol. 26
Issue 5
Pg. 359-64
ISSN: 1945-8932 [Electronic] United States |
PMID | 23168149
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Androstadienes
- Biomarkers
- Interleukin-17
- MUC5AC protein, human
- Mucin 5AC
- Fluticasone
|
Topics |
- Administration, Intranasal
- Adult
- Androstadienes
(administration & dosage)
- Biomarkers
(metabolism)
- Drug Resistance
- Female
- Fluticasone
- Gene Expression Regulation
(drug effects, immunology)
- Humans
- Interleukin-17
(metabolism)
- Male
- Middle Aged
- Mucin 5AC
(metabolism)
- Nasal Mucosa
(drug effects, immunology)
- Rhinitis, Allergic, Perennial
(drug therapy)
- Rhinitis, Allergic, Seasonal
(drug therapy)
- Young Adult
|